MeCP2 in the enteric nervous system

Area of Science:

• Neuroscience
• Gastroenterology
• Developmental Biology

Background:

• Rett syndrome (RTT) is a neurodevelopmental disorder affecting girls, characterized by intellectual disability and movement disorders.
• While central nervous system dysfunction is recognized, the causes of peripheral ailments like gastrointestinal (GI) dysfunction in RTT remain unclear.
• The role of the MeCP2 gene in the peripheral nervous system, particularly the GI tract, is not well-established.

Purpose of the Study:

• To investigate the expression and localization of the MeCP2 protein within the gastrointestinal tract.
• To determine if MeCP2 is present in the enteric nervous system (ENS), which controls gut function.
• To analyze MeCP2 expression patterns during different developmental stages in both human and murine GI tissues.

Main Methods:

• Immunohistochemistry was employed to detect MeCP2 and neuronal markers (HuC/D, juvenile beta tubulin, GFAP) in human and murine intestinal tissues.
• Western blot analysis was performed to quantify MeCP2 protein levels and assess specific neuronal markers (vAChT, nNOS) in GI tissues.
• Expression analysis spanned various developmental time points in murine models.

Main Results:

• MeCP2 protein was detected throughout the entire length of the GI tract in both species.
• Specifically, MeCP2 expression was localized to neurons within the enteric nervous system.
• MeCP2 expression was observed in the developing GI tract, with detectable levels by embryonic day 11.5 in mice.

Conclusions:

• The presence of MeCP2 in enteric neurons provides a potential explanation for GI dysmotility observed in Rett syndrome.
• This suggests that mutations in MeCP2 may lead to dysfunction of the enteric neural network, contributing to intestinal problems in RTT patients.
• Further research into MeCP2's role in the ENS is warranted to understand and potentially treat GI complications in Rett syndrome.